Headquarters
12200 N STEMMONS FWY, STE 100, DALLAS, TX 75234-5877, US
DALLAS, TX, US
DIALECTIC THERAPEUTICS, INC.
From the company
Dialectic Therapeutics is a clinical-stage biotechnology company based in Dallas, Texas, dedicated to developing innovative anti-cancer drugs. Its lead candidate, DT2216, is built on its proprietary Antiapoptotic Protein Targeted Degradation (APTaD™) technology platform and selectively induces cancer cells to degrade BCL-XL. DT2216 is in Phase 1/2 clinical trials for Fibrolamellar Carcinoma and Platinum-Resistant Ovarian Cancer.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.